Thyroid
|
October 8, 2024

Radioactive Iodine As A Potential Treatment For Hyperthyroidism

Written By
Medically Reviewed by
Updated On
October 24, 2024

Hyperthyroidism occurs when the thyroid gland produces too much thyroid hormone, which affects metabolism, heart rate, and energy levels. This condition can lead to symptoms such as weight loss, rapid heartbeat, and anxiety. Without treatment, hyperthyroidism may cause serious health problems like heart issues and weakened bones.

Effective treatment is essential for managing hyperthyroidism and improving quality of life. This article focuses on radioactive iodine therapy, a common treatment option that may help reduce thyroid activity and support balanced hormone levels.a common treatment option that helps reduce thyroid activity and restore balanced hormone levels.

[signup]

Understanding Hyperthyroidism

The thyroid gland is a small, butterfly-shaped gland located in the neck. It plays a central role in regulating metabolism, which is how the body converts food into energy. The thyroid produces two important hormones: thyroxine (T4) and triiodothyronine (T3). These hormones help control heart rate, body temperature, and energy use.

Hyperthyroidism occurs when the thyroid gland produces too much T4 and T3. This excess of hormones speeds up metabolism, potentially affecting various symptoms and health issues. One common cause is Graves’ disease, an autoimmune condition where the immune system mistakenly attacks the thyroid. Other causes include toxic nodular goiter (lumps in the thyroid) and thyroiditis, which is inflammation of the thyroid.

Symptoms of hyperthyroidism can vary but often include weight loss, a rapid or irregular heartbeat, anxiety, sweating, and trouble sleeping.Β 

Doctors typically use blood tests to measure thyroid hormone levels and thyroid-stimulating hormone (TSH) to diagnose the condition. Another common test is the radioactive iodine uptake test, which helps assess how much iodine the thyroid absorbsβ€”an important factor in diagnosing the condition.

Overview of Hyperthyroidism Treatment Options

There are several ways to treat hyperthyroidism, and the right option depends on the cause, your overall health, and personal preferences.

1. Medications for Hyperthyroidism

Antithyroid drugs are commonly used to manage hyperthyroidism, particularly for people with Graves' disease. These drugs work by blocking the thyroid from producing too much hormone.

The two most commonly prescribed antithyroid drugs are:

  • Methimazole: The first choice for most patients because it is effective and has fewer side effects.
  • Propylthiouracil (PTU): Sometimes used during pregnancy or in people who can't take methimazole.

Antithyroid drugs are often used as the first line of treatment, especially in mild to moderate cases of hyperthyroidism. They help reduce thyroid hormone levels, which can help with symptoms of fast heartbeat, sweating, and nervousness. These drugs may take several weeks to start working, and most people need to stay on them for 1 to 2 years.

2. Radioactive Iodine Therapy

Radioactive iodine therapy is a common and effective treatment for hyperthyroidism. This method uses a small dose of radioactive iodine (iodine-131) to target part of the thyroid gland, potentially reducing its ability to produce excess hormones.

The thyroid naturally absorbs iodine from the bloodstream to produce hormones. By taking radioactive iodine, the radiation targets the thyroid, gradually shrinking it and lowering hormone levels. Most people take RAI as a one-time pill, but it may take several months to see the full effect.

3. Surgical Treatments

In some cases, surgery may be necessary to remove all or part of the thyroid gland. This procedure, called a thyroidectomy, is often used when:

  • The thyroid is very large (causing difficulty breathing or swallowing).
  • Medications or RAI are not suitable or effective.
  • Cancer is suspected alongside hyperthyroidism.

During surgery, the surgeon removes part (subtotal thyroidectomy) or all (total thyroidectomy) of the thyroid gland. If the entire gland is removed, patients will need to take thyroid hormone replacement pills for life.

What is Radioactive Iodine Therapy?

Radioactive iodine (RAI) therapy is a treatment that uses a small, safe dose of radioactive iodine to target the thyroid gland. Iodine is an essential element that the thyroid naturally absorbs to produce hormones. By using a radioactive form of iodine (I-131), the treatment shrinks or destroys part of the overactive thyroid tissue. This helps reduce the production of thyroid hormones, gradually bringing hormone levels back to normal.

RAI therapy was first introduced in the 1940s and has since become a common treatment for hyperthyroidism, especially in cases like Graves’ disease or toxic nodular goiter. It’s a well-established, non-invasive option with a long history of successful outcomes.

How It Fits Into Treatment Plans

RAI therapy is often chosen for its potential to provide a long-term solution for hyperthyroidism without the need for surgery. It is typically recommended when antithyroid medications are not effective or cause side effects or when long-term treatment is needed.Β 

Unlike surgery, RAI therapy doesn’t require a hospital stay and has a lower risk of complications. It’s especially favored for adults with persistent hyperthyroidism, offering a reliable and effective option for managing the condition.

How Radioactive Iodine Works

The treatment specifically targets the thyroid cells without affecting other tissues by using a radioactive form of iodine. When a person takes RAI, typically as a pill or liquid, the radioactive iodine (most often iodine-131) enters the bloodstream and is absorbed by the thyroid gland.Β 

Once inside the thyroid, the iodine-131 releases radiation that targets the overactive thyroid cells, gradually reducing their activity. The thyroid shrinks as these cells are destroyed, and its hormone production decreases. This process happens gradually, with the full effects of the treatment taking several weeks or months to appear.

The radiation from iodine-131 primarily affects the thyroid, reducing the risk of side effects in other body parts. However, because the treatment destroys some thyroid cells, many patients may develop hypothyroidism (low thyroid function) after treatment, which can be easily managed with thyroid hormone replacement pills.

Types of Radioactive Iodine Used

There are two main types of radioactive iodine used in medical treatments: iodine-131 and iodine-123. Although both are radioactive, they have different uses in treating and diagnosing thyroid conditions.

1. Iodine-131 (I-131)

Iodine-131 is the type of radioactive iodine most commonly used to treat hyperthyroidism. It emits both beta particles and gamma rays, but the beta particles do most of the work by destroying the overactive thyroid cells. I-131 has a half-life of about eight days, meaning it stays in the body long enough to have a therapeutic effect but gradually breaks down over time.

2. Iodine-123 (I-123)

Iodine-123 is a different form of radioactive iodine primarily used for diagnostic purposes. It emits gamma rays, which can be detected by imaging equipment to give doctors a clear picture of how well the thyroid is functioning. Unlike I-131, I-123 does not destroy thyroid tissue because it emits no beta particles.

Absorption and Distribution

When ingested, radioactive iodine is absorbed through the stomach and intestines into the bloodstream. The iodine quickly travels to the thyroid gland and is taken up by the overactive thyroid cells. Since the thyroid is the only part of the body that actively uses iodine, the radioactive material concentrates almost exclusively in the thyroid, making the treatment very targeted.

The thyroid uses iodine to produce hormones, so it absorbs the iodine-131 from the bloodstream. Radioactive iodine mimics the natural iodine that the thyroid uses, which is why it can specifically target thyroid cells. While most of the radioactive iodine goes to the thyroid, small amounts may circulate to other tissues or be eliminated through urine, sweat, or saliva.Β 

This is why people undergoing RAI therapy are advised to take certain precautions, such as limiting close contact with others (especially children and pregnant women) and maintaining good hygiene for a few days after treatment to minimize radiation exposure to those around them.

Indications for Radioactive Iodine Treatment

Doctors may recommend RAI based on the following factors:

  • Severity of Hyperthyroidism: RAI is often preferred in moderate to severe cases of hyperthyroidism, especially when antithyroid medications are ineffective or not well-tolerated.
  • Recurrent Hyperthyroidism: RAI is commonly chosen for patients who experience hyperthyroidism that comes back after stopping antithyroid drugs. RAI offers a more long-term solution than medications.
  • Patient Preference: Some patients may prefer RAI because it is a non-surgical and relatively simple procedure that can be done in one or two sessions. It doesn’t involve daily medications, unlike antithyroid drugs.
  • Contraindications to Surgery: RAI is often recommended for patients who are not good candidates for surgery due to age, medical conditions, or personal preference to avoid invasive procedures.
  • Large Goiters: In some cases, RAI can help shrink large goiters (an enlarged thyroid gland) that cause symptoms like difficulty breathing or swallowing. This treatment may reduce the size of the goiter without the need for surgery.
  • Thyroid Cancer: RAI is sometimes used after thyroid cancer surgery to eliminate any remaining thyroid cells and reduce the risk of cancer recurrence.

Suitability for Different Patient Groups

RAI therapy is not suitable for everyone. Doctors carefully consider a patient's age, overall health, and life circumstances when recommending this treatment.

1. Adults

RAI is generally considered a safe and effective treatment option for many adults with hyperthyroidism. It is often the preferred treatment for middle-aged and older adults, as it offers a long-term solution and avoids the potential risks associated with surgery. Adults who have experienced relapse after antithyroid medications or have significant thyroid overactivity often find RAI to be an effective long-term solution.

2. Children and Adolescents

RAI is used less frequently in children and adolescents. Although it can be effective, it is typically reserved for cases where other treatments, such as antithyroid drugs, have not worked or are not tolerated.Β 

Doctors tend to prioritize medication in younger patients since RAI may permanently alters thyroid function, and the long-term effects on growing children are less well-studied. In some cases, surgery might be preferred for younger patients.

In cases of severe or recurrent hyperthyroidism, or if medications are ineffective and surgery is not an option, RAI may be used cautiously in children and adolescents.

3. Pregnant and Breastfeeding Women

RAI is not recommended for pregnant women because the radiation can cross the placenta and affect the developing baby. Similarly, breastfeeding women are advised to avoid RAI therapy because the radioactive iodine can be passed to the baby through breast milk.

Women who plan to get pregnant are usually advised to avoid pregnancy for at least six months after receiving RAI to allow sufficient time for the radioactive iodine to clear the body.

4. Elderly Patients

Older adults with hyperthyroidism, especially those with large goiters or toxic nodules, are often ideal candidates for RAI because it avoids the risks of surgery. RAI is considered safe in the elderly population and can help prevent complications related to prolonged hyperthyroidism, such as heart problems or bone loss.

Preparing for Radioactive Iodine Therapy

Several medical assessments are needed before undergoing radioactive iodine (RAI) therapy to ensure it's the right option for the patient. Doctors typically conduct blood tests to measure thyroid hormone levels and assess thyroid function.Β 

A radioactive iodine uptake test may also be done to determine how much iodine the thyroid absorbs. In some cases, ultrasound is used to check for nodules or structural changes in the thyroid. These evaluations help the doctor plan the correct dose of radioactive iodine for treatment.

Medications and Dietary Restrictions

In the weeks leading up to RAI therapy, patients may need to stop taking certain medications, particularly antithyroid drugs like methimazole or propylthiouracil, which can interfere with the treatment’s effectiveness.Β 

Patients may also be asked to follow a low-iodine diet for about 1 to 2 weeks before treatment. This involves avoiding foods rich in iodine, such as seafood, dairy products, and iodized salt, to help the thyroid absorb the radioactive iodine during therapy.

Informed Consent

Before proceeding with RAI therapy, the patient will undergo an informed consent process. This involves discussing the procedure with the healthcare provider to ensure the patient understands it, including how it works, the expected outcomes, and the potential risks.Β 

Common risks include temporary symptoms like sore throat or dry mouth and, in rare cases, permanent hypothyroidism, where the thyroid becomes underactive. Patients are informed about safety precautions to follow after treatment, such as avoiding close contact with others for a short period due to the radiation.Β 

Understanding both the benefits and risks helps patients make an informed decision about their treatment.

The Radioactive Iodine Treatment Procedure

RAI is almost always administered orally. There are two main ways it can be given:

  • Capsule: The most common method of RAI administration is through a capsule that contains radioactive iodine. This capsule is swallowed with water, similar to taking any other medication. It is tasteless and easy to swallow.
  • Liquid Form: In some cases, RAI is given as a liquid solution that the patient drinks. The liquid has a mild taste but is just as effective as the capsule.

After ingestion, the iodine is absorbed into the bloodstream and travels to the thyroid, where it accumulates and begins to work.Β 

While RAI is typically taken orally, it can be administered intravenously in rare cases, such as for patients who have trouble swallowing pills or cannot take it orally for other reasons. However, this is uncommon.

Dosage and Treatment Schedule

The dosage of RAI varies depending on the severity of hyperthyroidism, the size of the thyroid gland, and other patient factors, such as age and overall health.

  • Low Dose: For mild cases of hyperthyroidism, a smaller dose of RAI may be sufficient to reduce thyroid hormone production. This is often used for smaller goiters or milder symptoms.
  • Moderate Dose: A moderate dose is typically recommended for patients with more significant hyperthyroidism or toxic nodules.
  • High Dose: A higher dose may be required to reduce thyroid hormone levels effectively in severe cases, such as with Graves' disease or large toxic goiters.

Most patients need just one dose of RAI therapy. In rare cases, a second dose may be required if thyroid hormone levels remain too high after several months. The therapy is usually given on an outpatient basis, meaning you don’t need to stay in the hospital overnight.

What to Expect During the Procedure

On the day of treatment, patients will typically arrive at the medical facility, where a healthcare provider will go over final instructions. The actual process is quick:

  • Pre-Treatment Instructions: The doctor will review any necessary dietary or medication restrictions, ensuring the patient has followed the pre-treatment plan.
  • Administration of RAI: The patient is given the radioactive iodine to swallow in either pill or liquid form. The dose is measured based on the treatment plan.
  • Waiting Period: After ingesting the RAI, patients may need to remain at the facility for a short observation period. However, most people can leave shortly after taking the iodine.
  • Precautions Post-Treatment: Patients are instructed to follow specific safety guidelines for a few days after the procedure to limit radiation exposure to others. This can include staying a certain distance from people, especially children and pregnant women, and avoiding close contact with pets. Good hygiene, such as frequent handwashing and flushing the toilet twice after use, is also advised to reduce radiation spread.

Most patients don’t feel any discomfort during or immediately after taking the dose. It’s a relatively straightforward process, though the effects on the thyroid will take several weeks to fully develop.

Recovery and Aftercare

After RAI treatment, it’s essential to follow specific instructions to minimize radiation exposure to others and manage any side effects.

Post-Treatment Instructions

For the first few days after treatment, small amounts of radiation may still be present in your saliva, urine, and sweat. To reduce radiation exposure to others:

  • Avoid close contact: Stay at least 6 feet away from others, especially children and pregnant women, for the first 3 to 5 days.
  • Sleep separately: Sleep in a separate bed for a few nights.
  • Bathroom precautions: Use your own bathroom if possible, and flush the toilet twice after each use to reduce radiation in the waste.
  • Hygiene: Wash your hands frequently and avoid sharing towels, utensils, or food with others.

Follow-Up Appointments

RAI therapy doesn’t work instantly. It takes several weeks to months for the thyroid to shrink and hormone levels to decrease. You’ll need follow-up blood tests to monitor your thyroid hormone levels. These tests typically occur every 4 to 6 weeks during the first few months after treatment.

If the thyroid is destroyed or hormone production becomes too low (hypothyroidism), you will likely need to start taking daily thyroid hormone replacement pills.Β 

Benefits of Radioactive Iodine Therapy

Radioactive iodine (RAI) therapy is highly effective in treating hyperthyroidism. It works by gradually reducing the thyroid’s ability to produce excess hormones. Studies suggest that a single treatment may help normalize thyroid hormone levels in 80-90% of patients.Β 

The long-term outcome is often excellent, with most patients experiencing a significant reduction in symptoms like rapid heartbeat, anxiety, and weight loss.Β 

In many cases, RAI provides a permanent solution, although some patients may develop hypothyroidism, which can be easily managed with medication.

Non-Invasive Nature

Unlike surgery, which requires anesthesia and a hospital stay, RAI therapy is non-invasive. It involves swallowing a pill or liquid without an incision or stitches.Β 

This makes it a less stressful option for many patients, particularly those who want to avoid the risks associated with surgery, such as infection, scarring, or damage to the vocal cords and nearby structures in the neck.Β 

Additionally, there is no recovery time like there is with surgery, and most patients return to normal activities within a few days.

Convenience and Accessibility

Radioactive iodine therapy is usually done as an outpatient procedure, meaning there is no need for a hospital stay. The process is typically quick, taking less than an hour from start to finish, and many patients only require one treatment.Β 

It is widely available and accessible to many people, involving minimal disruption to daily life. The convenience of RAI therapy, along with its high success rate and non-invasive nature, makes it a preferred treatment option for many individuals dealing with hyperthyroidism.

Risks and Side Effects

While radioactive iodine (RAI) therapy is generally well-tolerated, some patients may experience mild side effects. These can include:

  • Nausea
  • Neck Tenderness or Swelling
  • Temporary Worsening of Hyperthyroid Symptoms

These side effects are usually short-lived and manageable, with symptoms often resolving within a few days to weeks.

Long-Term Risks

The most common long-term effect of RAI therapy is the development of hypothyroidism. This occurs when the thyroid becomes underactive due to the radioactive iodine, and hormone levels drop too low. Hypothyroidism is generally considered a manageable condition and is typically treated with daily thyroid hormone replacement medication.

Other rare long-term risks include:

  • Dry Eyes: This may happen if the tear glands are affected by the radiation, particularly in patients who wear contact lenses.
  • Radiation Exposure Concerns: Though RAI therapy uses a small, targeted dose of radiation, the overall risk to the body is low. The radiation primarily affects the thyroid, and any excess iodine is usually excreted in the urine within a few days. Patients are advised to follow precautions to limit exposure to others, but radiation-related health issues are extremely rare.

Managing Side Effects

To reduce or manage side effects, patients can take several steps:

  • Stay Hydrated: Drinking plenty of water helps flush excess iodine from the body.
  • Neck Relief: Over-the-counter pain relievers, such as acetaminophen or ibuprofen, can help ease neck discomfort or swelling.
  • Monitor for Hypothyroidism: Regular blood tests after treatment will monitor thyroid hormone levels. If hypothyroidism develops, hormone replacement therapy may be prescribed to maintain normal levels.
  • Precautions: Following post-treatment guidelines, such as avoiding close contact with others for a few days and practicing good hygiene, helps reduce any risks related to radiation exposure.

Long-Term Outcomes

After radioactive iodine (RAI) therapy, many patients develop hypothyroidism within weeks to months. This is an expected outcome, as the therapy aims to reduce overactive thyroid tissue, often leading to lower hormone production over time.Β 

Around 80-90% of patients require lifelong thyroid hormone replacement therapy (like levothyroxine) to maintain normal hormone levels. This treatment is simple and generally well-tolerated, requiring regular monitoring through blood tests to adjust dosages as needed.

For most patients, RAI therapy significantly improves symptoms. By bringing thyroid hormone levels into balance, patients often experience better overall health and an improved quality of life. Once hypothyroidism is controlled with hormone replacement, most people can lead normal, symptom-free lives.

While RAI therapy is highly effective in permanently reducing thyroid function, regular follow-up care is essential. Doctors will monitor thyroid hormone levels to ensure the condition does not return or shift into hypothyroidism. In rare cases where hyperthyroidism persists or returns, a second RAI treatment or other interventions may be needed.

Special Considerations

There are specific groups of people for whom radioactive iodine therapy may not be the best choice. Pregnancy, age, and other health conditions can affect the suitability of RAI, making it essential to tailor treatment options to each patient’s situation.

Pregnancy and Breastfeeding

RAI therapy is not safe for pregnant or breastfeeding women. The radioactive iodine can cross the placenta and harm the developing baby’s thyroid. Women who are pregnant or planning to become pregnant should avoid RAI therapy and may need to consider alternative treatments like medications or surgery. It’s recommended to wait at least six months after RAI treatment before attempting pregnancy to ensure the iodine has fully cleared from the body.

Age-Related Considerations

Children are generally not first-line candidates for RAI due to concerns about long-term effects on growth and development. Doctors often recommend medications or surgery for younger patients. Older adults are more likely to be candidates for RAI therapy, especially since it is a non-invasive option and carries fewer immediate risks compared to surgery.

Underlying Health Conditions

For patients with heart disease, severe hyperthyroidism can worsen cardiac issues. RAI therapy can be a safer option than surgery, which carries a higher risk for those with heart conditions. Patients with other comorbidities, like liver or kidney disease, should also consult with their doctors about the best treatment option.

Frequently Asked Questions (FAQs)

Patients often have many questions and concerns before undergoing RAI therapy. This section answers common questions about radiation exposure, isolation guidelines, and any long-term health effects, helping to ease anxieties and clarify practical considerations for treatment.

Q: Is RAI safe?

A: Yes, RAI has been used for decades and has a strong safety record. The radioactive iodine targets only the thyroid gland, and studies show no increased long-term cancer risk in most patients.

Q: Will I need isolation after treatment?

A: You may need to limit close contact with others for a few days to a week, especially around children and pregnant women. Instructions will depend on the dose you receive.

Q: What is the duration of isolation?

A: You’ll typically be advised to sleep in a separate bed, avoid physical contact, and maintain a distance from others for 3 to 7 days post-treatment.

Q: Is there an impact on daily activities?

A: Most people can return to normal activities within a few days, but you may need to avoid crowded places, like public transport or work, during the initial days after treatment.

Q: Cancer risks?

A: The risk of cancer from RAI therapy is extremely low. Studies have found no significant increase in cancer rates among patients who have undergone RAI for hyperthyroidism.

Q: Other long-term effects

A: Apart from hypothyroidism, which is manageable with medication, the majority of patients do not experience serious long-term health issues following RAI therapy.

[signup]

Key Takeaways

  • Hyperthyroidism occurs when the thyroid produces too much hormone, leading to symptoms like weight loss, rapid heart rate, and anxiety, and can cause serious health problems if untreated.
  • Radioactive iodine (RAI) therapy is a common, non-invasive treatment that uses a small dose of radioactive iodine to reduce thyroid hormone production by shrinking the thyroid gland.
  • RAI therapy is considered highly effective, offering a long-term solution in many cases. However, it often leads to hypothyroidism, which requires lifelong thyroid hormone replacement therapy.
  • Patients may need to follow precautions post-treatment to limit radiation exposure to others, but side effects are usually mild and manageable.
  • RAI is not suitable for pregnant or breastfeeding women, and its suitability varies by age, health conditions, and patient preference, making individualized treatment plans essential.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Abdi, Hengameh, et al. β€œAntithyroid Drugs.” Iranian Journal of Pharmaceutical Research : IJPR, vol. 18, no. Suppl1, 2019, pp. 1–12, www.ncbi.nlm.nih.gov/pmc/articles/PMC7393052/, https://doi.org/10.22037/ijpr.2020.112892.14005.

After radioactive iodine treatment for thyroid cancer. (n.d.). Www.cancerresearchuk.org. https://www.cancerresearchuk.org/about-cancer/thyroid-cancer/treatment/radiotherapy/radioactive-iodine-treatment/after-radioactive-iodine-treatment#:~:text=A%20small%20amount%20of%20radiation

Alvi, Asim Munir, et al. β€œEfficacy of Radioiodine Therapy in Patients with Primary Hyperthyroidism: An Institutional Review from Pakistan.” Cureus, vol. 14, no. 5, 1 May 2022, p. e24992, pubmed.ncbi.nlm.nih.gov/35719786/, https://doi.org/10.7759/cureus.24992.

American Thyroid Association. (n.d.). Thyroid Hormone Treatment. American Thyroid Association. https://www.thyroid.org/thyroid-hormone-treatment/

Armstrong, M., Numan Aziz, & Fingeret, A. (2019, June 28). Physiology, Thyroid Function. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537039/

Biello, A., Kinberg, E. C., & Wirtz, E. D. (2022, November 14). Thyroidectomy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK563279/

CampennΓ¬, A., Avram, A. M., Verburg, F. A., Ioannis Iakovou, Heribert HΓ€nscheid, Bart de Keizer, Petra PetranoviΔ‡ Ovčariček, & Luca Giovanella. (2023). The EANM guideline on radioiodine therapy of benign thyroid disease. European Journal of Nuclear Medicine and Molecular Imaging, 50(11), 3324–3348. https://doi.org/10.1007/s00259-023-06274-5

Cavalheiro, B. G., Shah, J. P., Randolph, G. W., Medina, J. E., Tufano, R. P., Zafereo, M., Hartl, D. M., Nixon, I. J., Guntinas-Lichius, O., Vander Poorten, V., LΓ³pez, F., Khafif, A. H., Owen, R. P., Shaha, A., Rodrigo, J. P., Rinaldo, A., MΓ€kitie, A. A., Silver, C. E., Sanabria, A., & Kowalski, L. P. (2023). Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review. Cancers, 15(3), 923. https://doi.org/10.3390/cancers15030923

CDC. (2024, April 23). Iodine-131. Radiation Emergencies. https://www.cdc.gov/radiation-emergencies/hcp/isotopes/iodine-131.html

Christie, J. (2022, December 6). The ultimate guide to thyroid hormones. Rupa Health. https://www.rupahealth.com/post/a-complete-guide-to-thyroid-hormones-a-functional-medicine-approach

Cleveland Clinic. (2024, April 29). What Is Radioactive Iodine? Cleveland Clinic. https://my.clevelandclinic.org/health/procedures/radioactive-iodine-therapy

Cloyd, J. (2024, January 8). The Science of Hydration: How Water Intake Affects Overall Health. Rupa Health. https://www.rupahealth.com/post/the-science-of-hydration-how-water-intake-affects-overall-health

Daniels, G. H., & Ross, D. S. (2023). Radioactive Iodine: A Living History. Thyroid, 33(6), 666–673. https://doi.org/10.1089/thy.2022.0344

De Leo, S., Lee, S. Y., & Braverman, L. E. (2019). Hyperthyroidism. The Lancet, 388(10047), 906–918. https://doi.org/10.1016/s0140-6736(16)00278-6

DeCesaris, L. (2022, August 8). Worried About Your Thyroid Health? Ask Your Doctor For These 3 Thyroid Labs. Rupa Health. https://www.rupahealth.com/post/treating-the-thyroid-naturally

Eghtedari, B., & Correa, R. (2023). Levothyroxine. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539808/

Fard-Esfahani, A., Emami-Ardekani, A., Fallahi, B., Fard-Esfahani, P., Beiki, D., Hassanzadeh-Rad, A., & Eftekhari, M. (2014). Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nuclear Medicine Communications, 1. https://doi.org/10.1097/mnm.0000000000000132

Gerriets, V., Anderson, J., Patel, P., & Nappe, T. M. (2024, January 11). Acetaminophen. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482369/#:~:text=Acetaminophen%2C%20also%20known%20as%20N

Gupta, A., & Rehman, A. (2020). Propylthiouracil (PTU). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549828/

Gurgul, E., & Sowinski, J. (2011). Primary hyperthyroidism--diagnosis and treatment. Indications and contraindications for radioiodine therapy. Nuclear Medicine Review. Central & Eastern Europe, 14(1), 29–32. https://pubmed.ncbi.nlm.nih.gov/21751169/

Henry, E. (2021, July 16). A Functional Medicine Approach to Thyroid Hormone Labs. Www.rupahealth.com. https://www.rupahealth.com/post/a-functional-medicine-approach-to-thyroid-hormone-labs

IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. ANTI-THYROID DRUGS. Www.ncbi.nlm.nih.gov, International Agency for Research on Cancer, 2001, www.ncbi.nlm.nih.gov/books/NBK396260/.

Jonklaas, J. (2021). Optimal Thyroid Hormone Replacement. Endocrine Reviews, 43(2). https://doi.org/10.1210/endrev/bnab031

Kim, H. O., Lee, K., Lee, S. M., & Seo, G. H. (2020). Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer. JAMA Internal Medicine, 180(1), 54. https://doi.org/10.1001/jamainternmed.2019.4644

Kim, P. D., & Tran, H. D. (2021). I-123 Uptake. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559314/

Low Iodine Diet | American Thyroid Association. (2016). American Thyroid Association. https://www.thyroid.org/low-iodine-diet/

Ludwig, B., Ludwig, M., Dziekiewicz, A., Agnieszka MikuΕ‚a, Cisek, J., Biernat, S., & Kaliszewski, K. (2023). Modern Surgical Techniques of Thyroidectomy and Advances in the Prevention and Treatment of Perioperative Complications. Cancers, 15(11), 2931–2931. https://doi.org/10.3390/cancers15112931

Lutterman, S. L., Zwaveling-Soonawala, N., Verberne, H. J., Verburg, F. A., Trotsenburg, A. S. P. van, & Mooij, C. F. (2021). The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves’ Disease: A Systematic Review. European Thyroid Journal, 10(5), 353–363. https://doi.org/10.1159/000517174

Maholy, N. (2023, February 17). A functional medicine approach to anxiety: Testing, nutrition, & supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-anxiety

Mumtaz, M., Lin, L. S., Hui, K. C., & Mohd Khir, A. S. (2009). Radioiodine I-131 for the therapy of graves’ disease. The Malaysian Journal of Medical Sciences : MJMS, 16(1), 25–33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336179/

Neibling, K. (2023, February 7). What You Need to Know About The Thyroid Iodine Connection. Rupa Health. https://www.rupahealth.com/post/what-you-need-to-know-about-the-thyroid-iodine-connection

NIH. (1994). Iodine-131. PubMed; Organization of Teratology Information Specialists (OTIS). https://www.ncbi.nlm.nih.gov/books/NBK582769/

NIH. (2001). ANTI-THYROID DRUGS. In www.ncbi.nlm.nih.gov. International Agency for Research on Cancer. https://www.ncbi.nlm.nih.gov/books/NBK396260/

Orlander, P. R. (2022). Toxic Nodular Goiter Treatment & Management: Medical Care, Surgical Care, Consultations. EMedicine. https://emedicine.medscape.com/article/120497-treatment

Padda, I. S., & Nguyen, M. (2023, June 3). Radioactive Iodine Therapy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557741/

Radioactive Iodine Uptake Test - Endocrine Surgery | UCLA Health. (n.d.). Www.uclahealth.org. https://www.uclahealth.org/medical-services/surgery/endocrine-surgery/patient-resources/patient-education/endocrine-surgery-encyclopedia/radioactive-iodine-uptake-test

Ravichandran, R., Binukumar, J., & Al Saadi, A. (2010). Estimation of effective half life of clearance of radioactive Iodine (131I) in patients treated for hyperthyroidism and carcinoma thyroid. Indian Journal of Nuclear Medicine, 25(2), 49. https://doi.org/10.4103/0972-3919.72686

Ross, D. S. (2022). Radioiodine in the treatment of hyperthyroidism. Www.uptodate.com. https://www.uptodate.com/contents/radioiodine-in-the-treatment-of-hyperthyroidism

Samuels, M. H. (2021, August 9). Hyperthyroidism in Aging (K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J. M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D. L. Trence, & A. Vinik, Eds.). PubMed; MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK278986/

Singh, G., & Correa, R. (2020). Methimazole. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545223/

Song, A., Kim, S. J., Kim, M.-S., Kim, J., Kim, I., Bae, G. Y., Seo, E., Cho, Y. S., Choi, J. Y., Cho, S. Y., & Jin, D.-K. (2021). Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.687834

Sweetnich, J. (2023a, March 6). The Ultimate Guide to Hypothyroidism Lab Testing. Rupa Health. https://www.rupahealth.com/post/the-ultimate-guide-to-hypothyroidism-lab-testing

Sweetnich, J. (2023b, May 19). Complementary and Integrative Medicine Treatment for Thyroiditis: Specialty Testing, Nutrition, and Supplements. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatment-for-thyroiditis

Trung, V., & Bajaj, T. (2023). Ibuprofen. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK542299/

Wadsley, J., Armstrong, N., Bassett-Smith, V., Beasley, M., Chandler, R., Cluny, L., Craig, A. J., Farnell, K., Garcez, K., Garnham, N., Graham, K., Hallam, A., Hill, S., Hobrough, H., McKiddie, F., & Strachan, M. W. J. (2022). Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK. Clinical Oncology. https://doi.org/10.1016/j.clon.2022.07.002

Wan Mohamed, W. M. I., Sayuti, S. C., & Draman, N. (2018). Hypothyroidism and its associated factors after radioactive iodine therapy among patients with hyperthyroidism in the Northeast Coast State of Malaysia. Journal of Taibah University Medical Sciences, 13(5), 432–437. https://doi.org/10.1016/j.jtumed.2018.06.004

Weinberg, J. (2023a, January 24). Functional Medicine Treatment for Graves’ Disease. Rupa Health. https://www.rupahealth.com/post/functional-medicine-treatment-for-graves-disease

Weinberg, J. (2023b, February 7). A Functional Medicine Protocol for Hyperthyroidism. Rupa Health. https://www.rupahealth.com/post/5-functional-medicine-labs-that-can-assist-a-root-cause-treatment-for-hyperthyroidism

Weinberg, J. L. (2022, September 7). An Integrative Medicine Approach to Hypothyroidism. Rupa Health. https://www.rupahealth.com/post/understanding-hypothyroidism-and-how-to-treat-it-naturally

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Thyroid
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! πŸ‘‹ Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! πŸ‘‹ Join Dr. Terry Wahls for a 3-week bootcamp on integrating functional medicine into conventional practice, focusing on complex cases like Multiple Sclerosis. Learn to analyze labs through a functional lens, perform nutrition-focused physical exams, and develop personalized care strategies. Register Here.